论文部分内容阅读
目的探讨小骨窗开颅治疗在高血压脑出血中的临床价值,为其临床预防及治疗提供依据。方法总结并回顾性分析2011年6月至2016年7月喀什地区第一人民医院神经外科收治的175例经小骨窗开颅治疗高血压脑出血患者的相关临床资料,并结合文献分析。结果按多田公式计算,本组血肿清除率达85%以上140例(80%),70%~85%35例(20%)。术后死亡21例,死亡率为12.0%。生存154例(88.00%),术后随访6个月至1年,按日常生活能力(ADL)分级:1级68例,2级44例,3级35例,4级18例,5级10例,ADL评分1~3级占84.0%。结论小骨窗开颅是一种安全有效的高血压脑出血治疗方法,其临床疗效显著,术后创伤较小,能够促进患者健康,改善患者的生活,具有重要的临床意义。可以在临床上进一步推广。
Objective To investigate the clinical value of craniotomy in treatment of hypertensive intracerebral hemorrhage and provide the basis for its clinical prevention and treatment. Methods The clinical data of 175 patients with hypertensive intracerebral hemorrhage treated by small bone window craniotomy admitted in the Department of Neurosurgery, First People’s Hospital of Kashi Prefecture from June 2011 to July 2016 were retrospectively analyzed and analyzed retrospectively. Results According to the Tada formula, the group hematoma clearance rate of 85% or more 140 cases (80%), 70% ~ 85% 35 cases (20%). Twenty-one patients died after operation, with a mortality rate of 12.0%. Survival in 154 cases (88.00%) was followed up for 6 months to 1 year, according to ADL grading: 68 cases of grade 1, 44 cases of grade 2, 35 cases of grade 3, 18 cases of grade 4, 10 cases of grade 5 For example, ADL score 1 to 3 accounted for 84.0%. Conclusion Small craniotomy is a safe and effective treatment for hypertensive intracerebral hemorrhage. The clinical curative effect is obvious, the postoperative trauma is small, which can promote the health of patients and improve the life of patients. It is of important clinical significance. Can be further promoted in the clinic.